144 related articles for article (PubMed ID: 31605362)
1. The prevalence of heterozygous CYP21A2 deficiency in patients with idiopathic acne, hirsutism, or both.
Gao Y; Yu B; Mao J; Wang X; Nie M; Wu X
Endocrine; 2020 Mar; 67(3):665-672. PubMed ID: 31605362
[TBL] [Abstract][Full Text] [Related]
2. A rational, non-radioactive strategy for the molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Coeli-Lacchini FB; Turatti W; Elias PC; Elias LL; Martinelli CE; Moreira AC; Antonini SR; de Castro M
Gene; 2013 Sep; 526(2):239-45. PubMed ID: 23570880
[TBL] [Abstract][Full Text] [Related]
3. [Detection of CYP21A2 gene mutations and the differences in the levels of hormones in patients with 21-hydroxylase deficiency].
Gao YJ; Yu BQ; Lu L; Wu XY; Mao JF; Wang X; Tong AL; Chen S; Nie M
Zhonghua Yi Xue Za Zhi; 2020 Mar; 100(8):586-592. PubMed ID: 32164112
[No Abstract] [Full Text] [Related]
4. Comprehensive genotyping of Turkish women with hirsutism.
Polat S; Karaburgu S; Ünlühizarcı K; Dündar M; Özkul Y; Arslan YK; Karaca Z; Kelestimur F
J Endocrinol Invest; 2019 Sep; 42(9):1077-1087. PubMed ID: 30811025
[TBL] [Abstract][Full Text] [Related]
5. Adrenal androgen hyperresponsiveness to adrenocorticotropin in women with acne and/or hirsutism: adrenal enzyme defects and exaggerated adrenarche.
Lucky AW; Rosenfield RL; McGuire J; Rudy S; Helke J
J Clin Endocrinol Metab; 1986 May; 62(5):840-8. PubMed ID: 3007557
[TBL] [Abstract][Full Text] [Related]
6. [Molecular and clinical study on homozygous or heterozygous large deletion of
Gao YJ; Yu BQ; Lu L; Tong AL; Chen S; Mao JF; Wang X; Wu XY; Nie M
Zhonghua Yi Xue Za Zhi; 2019 Mar; 99(12):912-917. PubMed ID: 30917440
[No Abstract] [Full Text] [Related]
7. Carrier status for steroid 21-hydroxylase deficiency is only one factor in the variable phenotype of acne.
Ostlere LS; Rumsby G; Holownia P; Jacobs HS; Rustin MH; Honour JW
Clin Endocrinol (Oxf); 1998 Feb; 48(2):209-15. PubMed ID: 9579234
[TBL] [Abstract][Full Text] [Related]
8. Clinical and hormonal characteristics in heterozygote carriers of congenital adrenal hyperplasia.
Guarnotta V; Niceta M; Bono M; Marchese S; Fabiano C; Indelicato S; Di Gaudio F; Garofalo P; Giordano C
J Steroid Biochem Mol Biol; 2020 Apr; 198():105554. PubMed ID: 31805392
[TBL] [Abstract][Full Text] [Related]
9. [Analysis of copy number variation of
Gao YJ; Yu BQ; Lu L; Wu XY; Mao JF; Wang X; Tong AL; Chen S; Nie M
Zhonghua Yi Xue Za Zhi; 2019 Dec; 99(48):3765-3769. PubMed ID: 31874511
[No Abstract] [Full Text] [Related]
10. Mutational characterization of congenital adrenal hyperplasia due to 21-hydroxylase deficiency in Malaysia.
Balraj P; Lim PG; Sidek H; Wu LL; Khoo AS
J Endocrinol Invest; 2013 Jun; 36(6):366-74. PubMed ID: 23027774
[TBL] [Abstract][Full Text] [Related]
11. [Diagnostic value of multiplex ligation dependent probe amplification combined with Sanger sequencing in 21-hydroxylase deficiency].
Gao YJ; Yu BQ; Lu L; Tong AL; Chen S; Mao JF; Wang X; Wu XY; Nie M
Zhonghua Yi Xue Za Zhi; 2019 Feb; 99(6):432-437. PubMed ID: 30786337
[No Abstract] [Full Text] [Related]
12. Genetic defects in the cyp21a2 gene in heterozygous girls with premature adrenarche and adolescent females with hyperandrogenemia.
Neocleous V; Shammas C; Phedonos AP; Karaoli E; Kyriakou A; Toumba M; Phylactou LA; Skordis N
Georgian Med News; 2012 Sep; (210):40-7. PubMed ID: 23045419
[TBL] [Abstract][Full Text] [Related]
13. [Analysis of CYP21A2 gene mutations among patients with classical steroid 21-hydroxylase deficiency].
Su Y; Chen H; Zhu W; Wang J; Zhou J; Chen Y; Zhao H; Zeng Y; Lin F; Zhang H; Lin Q
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2016 Dec; 33(6):786-791. PubMed ID: 27984606
[TBL] [Abstract][Full Text] [Related]
14. [Correlation between variants of CYP21A2 gene promoter region and nonclassical 21-hydroxylase deficiency].
Huang S; Su Z; Zhang L; Zhao X; Wen P
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2020 Aug; 37(8):815-818. PubMed ID: 32761585
[TBL] [Abstract][Full Text] [Related]
15. 17-Hydroxyprogesterone Response to Standard Dose Synacthen Stimulation Test in
Polat S; Arslan YK
J Clin Res Pediatr Endocrinol; 2022 Mar; 14(1):56-68. PubMed ID: 34743977
[TBL] [Abstract][Full Text] [Related]
16. Differences in hormonal levels between heterozygous
Silva RS; Carvalho B; Pedro J; Castro-Correia C; Carvalho D; Carvalho F; Fontoura M
Arch Endocrinol Metab; 2022 Apr; 66(2):168-175. PubMed ID: 35289513
[TBL] [Abstract][Full Text] [Related]
17. The presence of the 21-hydroxylase deficiency carrier status in hirsute women: phenotype-genotype correlations.
Escobar-Morreale HF; San Millán JL; Smith RR; Sancho J; Witchel SF
Fertil Steril; 1999 Oct; 72(4):629-38. PubMed ID: 10521100
[TBL] [Abstract][Full Text] [Related]
18. Clinical phenotype and mutation spectrum of the CYP21A2 gene in patients with steroid 21-hydroxylase deficiency.
Choi JH; Jin HY; Lee BH; Ko JM; Lee JJ; Kim GH; Jung CW; Lee J; Yoo HW
Exp Clin Endocrinol Diabetes; 2012 Jan; 120(1):23-7. PubMed ID: 22020670
[TBL] [Abstract][Full Text] [Related]
19. The frequency of CYP 21 gene mutations in Turkish women with hyperandrogenism.
Kelestimur F; Everest H; Dundar M; Tanriverdi F; White C; Witchel SF
Exp Clin Endocrinol Diabetes; 2009 May; 117(5):205-8. PubMed ID: 19085698
[TBL] [Abstract][Full Text] [Related]
20. CYP21A2 mutation analysis in Korean patients with congenital adrenal hyperplasia using complementary methods: sequencing after long-range PCR and restriction fragment length polymorphism analysis with multiple ligation-dependent probe amplification assay.
Hong G; Park HD; Choi R; Jin DK; Kim JH; Ki CS; Lee SY; Song J; Kim JW
Ann Lab Med; 2015 Sep; 35(5):535-9. PubMed ID: 26206692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
